Trillium Therapeutics Inc...

NASDAQ: TRIL · Real-Time Price · USD
18.44
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM

Trillium Therapeutics Revenue

Trillium Therapeutics reported an annual revenue of $148K, reflecting a 19.35% growth. For the quarter ending September 30, 2021, Trillium Therapeutics generated $0 in revenue.
Revenue (ttm)
148K
Revenue Growth
19.35%
Price / Sales Ratio
8324.29
Revenue / Employee
4.48K
Employees
33
Market Cap
0

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2020 148K +19.35%
Dec 31, 2019 124K +Infinity%
Dec 31, 2018 0 n/a
Dec 31, 2017 0 n/a
Dec 31, 2016 0 n/a
Dec 31, 2015 0 n/a
Dec 31, 2014 0 n/a
Dec 31, 2013 0 n/a
Dec 31, 2012 0 n/a
Dec 31, 2011 0 n/a
Dec 31, 2010 0 n/a
Dec 31, 2009 0 n/a
Dec 31, 2008 0 n/a
Dec 31, 2007 0 n/a
Dec 31, 2006 0 n/a
Dec 31, 2005 0 n/a
Dec 31, 2004 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.